ClinicalTrials.gg
RecruitingNCT07949994Updated Nov 20, 2026

SALUTOGENESIS MODEL

An interventional study of care based on the salutogenesis model in Bipolar Affective Disorder, sponsored by TC Erciyes University. Recruiting at 2 sites in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-20.

Sponsored by TC Erciyes University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Jun 2026; still recruiting 5 months later.
Updated Nov 20, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-20

Among 45 studies in Bipolar Disorder with a site in Turkey — 10 open to participants now, 11 under way, none of them phase 3. Bipolar Disorder · Turkey.

Planned enrollment
6th of 26
70 · median 50
Started
2026
with 5 others
No phase
18 of 45
4 open now
Primary completion
2026-11
later than 3 of 10 live
Registered
34th of 45
by date

Among the 45 studies in Bipolar Disorder with a site in Turkey, this one is the 6th largest by planned enrollment of the 26 interventional ones that give a count, is one of 6 that started in 2026, is one of 18 with no phase, reaches primary completion later than 3 of the 10 other live ones, and was the 34th registered.

Bipolar Disorder

1,687 studies on the registry are indexed under Bipolar Disorder; 268 are open to participants now.

Browse Bipolar Disorder studies →

Open to participants now

10 of the 45 studies in Bipolar Disorder with a site in Turkey are open now. Recruiting first, the newest first:

4 more — sign in →

All 10 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 207 Bipolar Disorder studies recruiting now, 59 (29%) set no upper age limit and 135 (65%) stop at 75 or younger; 38 take children under 18; 51 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 45 studies in Bipolar Disorder with a site in Turkey, or all of them as a file.
02

Study summary

This study aims to examine the effect of nursing care based on the salutogenesis model on the sense of integrity and functionality levels in individuals with bipolar disorder. The scope of the study includes the evaluation of the effects of model-based care initiatives applied to individuals diagnosed with bipolar disorder on individuals' psychosocial adaptation, stress coping capacity and daily life functionality.

The study focuses on preventive and developmental care approaches in the field of mental health and disease nursing. The research is experimental in nature and will be carried out in an intervention and control group design. Within the scope of the study, structured nursing care based on the salutogenesis model will be applied to the intervention group, while routine care will be provided to the control group. The data will be collected through the sociodemographic information form, the sense of integrity scale and valid and reliable scales that measure the level of functionality in bipolar disorder. By comparing the pre-test and post-test measurements, the effect of the maintenance model will be analyzed using statistical methods. The original value of the study is that nursing care based on the salutogenesis model was considered experimentally for the first time in individuals diagnosed with bipolar disorder. Although the use of this model in chronic diseases is limited in the literature, there are no studies aimed at its application in psychiatric diseases, especially bipolar disorder. In this aspect, the research offers a unique contribution in terms of integrating a theoretical model into clinical nursing practice.

As a result of the study, it is predicted that care based on the salutogenesis model strengthens the sense of integrity of individuals and increases their level of functionality. It is expected that the findings to be obtained will contribute to psychiatric nursing practices, the development of care plans and the improvement of the quality of mental health services, the increase of professional satisfaction of mental health workers and the prevention of burnout problems.

03

Conditions studied

  • Bipolar Affective Disorder

Browse trials for

Keywords

  • Bipolar Disorder
  • Salutogenesis Model
  • Care
  • Sense of Coherence
  • Functionality
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • all individuals diagnosed with bipolar disorder over the age of 18, who are not in an active illness attack with intelligence and meaning skills, who accepted the study.

Exclusion criteria

Exclusion Criteria:

  • people under the age of 18 who are in an active illness attack, have problems with understanding and intelligence, do not accept research.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
70 participants (estimated)

Study arms

  • No intervention
    Control Group

    Within the scope of the study, Certification maintenance application can be performed based on the variable series salutogenesis model, while routine maintenance can be performed in the control group. Organization of routine 4-session maintenance service of the control group.

  • Experimental
    The Universe and Sample of the Research

    The universe of the research will be composed of patients diagnosed with bipolar disorder admitted to psychiatric outpatient clinics of Niğde Ömer Halisdemir Training and Research Hospital within the date December determined for the scientific study. The sample size of the study was determined by Uzdil et al. based on the effect size obtained from the (2022) study, it was calculated with the G\*Power 3.1.9.2 program. In the analyses, the effect size was taken as d = 0.90, the confidence level α = 0.05 and the test strength (1-β) = 0.95 for two independent groups. According to the a priori power analysis, it was determined that a total of 68 people were needed in each group, including at least 34 participants. Taking into account the possible losses, it was planned to conduct the research with a total of 70 people, including 35 participants in each group.

    Behavioral: care based on the salutogenesis model

Interventions

  • Behavioralcare based on the salutogenesis model

    Care Guide Adapted from the Salutogenesis Model for Patients with Bipolar Disorder

06

What researchers measure

Primary outcomes

  1. Change in Sense of Coherence Score

    Sense of coherence will be assessed using the Sense of Coherence Scale. The effect of salutogenesis model-based nursing care on the sense of coherence of individuals with bipolar disorder will be evaluated by comparing changes in scores between the intervention and control groups across three assessment points.

    Time frame: At baseline, 3 months after baseline, and 6 months after baseline.

  2. Change in Functionality Score

    Functionality will be assessed using the Bipolar Disorder Functioning Questionnaire. The effect of salutogenesis model-based nursing care on the functionality of individuals with bipolar disorder will be evaluated by comparing changes in scores between the intervention and control groups across three assessment points.

    Time frame: At baseline, 3 months after baseline, and 6 months after baseline.

07

Study locations

1 of 2 sites recruiting
  • Niğde Ömer Halisdemir Training and Research hospital, NIĞDE, Niğde 51200
    Niğde, Niğde Province 51200, Turkey (Türkiye)
    Not yet recruiting
  • Niğde Ömer Halisdemir Eğitim ve Araştırma hastanesi
    Niğde, 51200, Turkey (Türkiye)
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — I will decide when the data reaches maturity

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2026 (actual). Primary completion is estimated for Nov 2026, 5 months after the start.

Of 358 non-industry interventional studies with no phase under Bipolar Disorder, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 58. This study's planned 5 months is below that.

Counting every sponsor, half of 360 studies reached it within 37 months; a quarter within 23 and three quarters within 58.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 13, 2026
First posted
Nov 20, 2026
StartActual
Jun 1, 2026
Primary completionEst.
Nov 28, 2026
CompletionEst.
Dec 15, 2026
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 20, 2026
Show all 1 update
  1. Nov 20, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07949994
Responsible party
Sezgın Kılıc (Doctoral Student in Nursing, TC Erciyes University) — Principal investigator
First posted
Nov 20, 2026
Start date
Jun 1, 2026
Primary completion
Nov 28, 2026 (estimated)
Completion
Dec 15, 2026 (estimated)
Last update
Nov 20, 2026

Study contacts

Sezgin Kılıç, PhD Student
Contact
sezar5184@hotmail.com
+90-5367004205

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion